Ligand profile
B1W
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00676 — Maltodextrin phosphorylase
Identifiers
Database identifiers and provenance.
- Ligand ID
B1W- PDB
5ox4- UniProt (similar protein)
P00489- Target protein
- KP13_00676
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 157.7
- −1 ≤ LogP ≤ 5 -1.43
- MW ≤ 500 Da 322.3
- LogP ≤ 5 -1.43
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 157.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1cc(ccc1c2[nH]c(nn2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Nc1cc(ccc1c2[nH]c(nn2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)N
InChI=1S/C14H18N4O5/c15-7-3-1-6(2-4-7)13-16-14(18-17-13)12-11(22)10(21)9(20)8(5-19)23-12/h1-4,8-12,19-22H,5,15H2,(H,16,17,18)/t8-,9-,10+,11-,12-/m1/s1InChI=1S/C14H18N4O5/c15-7-3-1-6(2-4-7)13-16-14(18-17-13)12-11(22)10(21)9(20)8(5-19)23-12/h1-4,8-12,19-22H,5,15H2,(H,16,17,18)/t8-,9-,10+,11-,12-/m1/s1
NDNZXPQRERAKKG-RMPHRYRLSA-NNDNZXPQRERAKKG-RMPHRYRLSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00343
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand B1W →
- PDB RCSB structure 5ox4 →
- UniProt UniProt P00489 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “B1W”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00676.
PDB 121
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).